Compare DSS & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSS | SSKN |
|---|---|---|
| Founded | 1984 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.7M | 8.9M |
| IPO Year | N/A | 2005 |
| Metric | DSS | SSKN |
|---|---|---|
| Price | $1.10 | $1.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 11.8K | ★ 100.2K |
| Earning Date | 11-14-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $22,046,000.00 | ★ $30,980,000.00 |
| Revenue This Year | $14.93 | N/A |
| Revenue Next Year | N/A | $7.74 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.53 | N/A |
| 52 Week Low | $0.72 | $1.18 |
| 52 Week High | $1.90 | $3.86 |
| Indicator | DSS | SSKN |
|---|---|---|
| Relative Strength Index (RSI) | 49.16 | 44.05 |
| Support Level | $0.91 | $1.18 |
| Resistance Level | $1.05 | $1.33 |
| Average True Range (ATR) | 0.07 | 0.06 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 34.57 | 9.09 |
DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.